Neuroscience
UT Health San Antonio obtained $46,707,168 in FY17 from the National Institutes of Health, Department of Defense, industry, and philanthropy to support multi-disciplinary research, teaching, and outreach programs.
UT Health San Antonio patented a discovery in protection against traumatic brain injury.
UT Health San Antonio is home to the Biggs Institute for Alzheimer and Neurodegenerative Diseases, dedicated to clinical research on Alzheimer’s.
Clinical trial participation is an invaluable way to contribute to the pursuit of new treatmetns for neurological diseases. Take action today...volunteer and play a role in finding a cure.
Find
UT Health is a leader in translational research studies on neurodegenerative diseases. We take research from the lab into clinical settings to understand the disease process in the brain and explore innovative ways to intervene and slow or stop disease.
Additional Highlights
-
Dr. Bieniek receives UT System's Rising STARs award
Kevin F. Bieniek, Ph.D., who is the inaugural director of the brain bank at UT Health San Antonio's Glen Biggs Institute for Alzheimer's and Neurodegenerative Diseases, has received a Rising STARs Award from the UT System.
Read the article at UT Health San Antonio's Newsroom -
Novel gene therapy reduces schizophrenia symptoms
Jennifer Donegan, Ph.D., and colleagues at UT Health San Antonio describe a novel, experimental approach to treating schizophrenia in the journal Nature Communications.
Read the article at UT Health San Antonio's Newsroom -
New therapy treatment could stop brain trauma seizures
Every year in San Antonio 30-40 people end up in a hospital with a traumatic brain injury, but the work being done by Dr. Mark Shapiro could make the effect of those a thing of the past.
Read more at UT Health San Antonio's Newsroom -
Dr. Frost receives TAMEST O'Donnell Award in Medicine
Instead of focusing on how to cure the disease, as is the focus of most Alzheimer's research, Dr. Frost's team looked at what causes the disease. In doing so, her team was able to identify targets that can mitigate the spread of toxic proteins in the brain.
Read the story at UT Health San Antonio's Newsroom